TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bioplanum AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
46
|
543
|
709 |
| Financial expenses |
2
|
5
|
4 |
| Earnings before taxes |
-87
|
220
|
110 |
| EBITDA |
-86
|
224
|
113 |
| Total assets |
180
|
258
|
353 |
| Current assets |
160
|
238
|
333 |
| Current liabilities |
144
|
35
|
183 |
| Equity capital |
36
|
223
|
170 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.0%
|
86.4%
|
48.2% |
| Turnover per employee |
46
|
543
|
709 |
| Profit as a percentage of turnover |
-189.1%
|
40.5%
|
15.5% |
| Return on assets (ROA) |
-47.2%
|
87.2%
|
32.3% |
| Current ratio |
111.1%
|
680.0%
|
182.0% |
| Return on equity (ROE) |
-241.7%
|
98.7%
|
64.7% |
| Change turnover |
-497
|
-166
|
277 |
| Change turnover % |
-92%
|
-23%
|
64% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.